MERCK Intraday Analysis...

MERCK Share Price

Open 965.50 Change Price %
High 970.50 1 Day -16.35 -1.69
Low 949.00 1 Week -6.15 -0.64
Close 953.40 1 Month -78.80 -7.63
Volume 12088 1 Year 237.55 33.18
52 Week High 1060.00
52 Week Low 620.00
MERCK Important Levels
Resistance 2 973.33
Resistance 1 965.12
Pivot 957.63
Support 1 941.68
Support 2 933.47
NSE INDIA Most Active Stocks
SUZLON 17.15 9.24%
FEDERALBNK 77.10 0.39%
JPASSOCIAT 10.25 0.49%
ESL 6.05 19.80%
ESL 6.05 19.80%
ESL 6.05 19.80%
ESL 6.05 19.80%
VISESHINFO 0.20 33.33%
IDEA 69.35 2.82%
TORNTPOWER 197.75 6.32%
More..
NSE INDIA Top Gainers Stocks
VKSPL 0.15 50.00%
VISESHINFO 0.20 33.33%
VIVIDHA 2.40 20.00%
ZUARI 337.60 19.99%
RUCHISOYA 24.05 19.95%
PREMIER 37.10 19.87%
ESL 6.05 19.80%
ESL 6.05 19.80%
ESL 6.05 19.80%
ESL 6.05 19.80%
More..
NSE INDIA Top Losers Stocks
AUSTRAL 0.35 -12.50%
NICCO 0.40 -11.11%
GOLDTECH 7.05 -7.24%
NHPC 27.80 -6.71%
ZENITHBIR 0.70 -6.67%
JIKIND 0.70 -6.67%
JAIHINDPRO 6.50 -6.47%
ITDC 279.50 -5.67%
JMA 181.55 -5.15%
MBLINFRA 56.10 -5.00%
More..

Merck Limited (NSE: MERCK)

MERCK Technical Analysis 3
As on 19th Jan 2017 MERCK Share Price closed @ 953.40 and we RECOMMEND Buy for LONG-TERM with Stoploss of 756.34 & Buy for SHORT-TERM with Stoploss of 943.70 we also expect STOCK to react on Following IMPORTANT LEVELS.
MERCK Target for January
1st Target up-side 1065.6
2nd Target up-side 1112.07
3rd Target up-side 1158.54
1st Target down-side 933
2nd Target down-side 886.53
3rd Target down-side 840.06
MERCK Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
MERCK Other Details
Segment EQ
Market Capital 5077698560.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.merck.co.in
MERCK Address
MERCK
Shiv Sagar Estate
7th Floor
Mumbai, 400018
India
Phone: 91 22 6660 9000
Fax: 91 22 2495 0307
MERCK Latest News
Cancer drug shortage sends patients on grim search   New York Post   - 22nd Mar 15
Award-Winning Actress S. Epatha Merkerson and Merck Challenge African ...   MarketWatch   - 20th Mar 15
Research cuts ripple across biopharma sector   Boston Globe (subscription)   - 19th Mar 15
Merck Limited   Moneycontrol.com   - 16th Mar 15
Merck Provides Regulatory Update on Investigational Medicine Sugammadex ...   MarketWatch   - 14th Mar 15
SPMS Drug Developer Opexa Therapeutics To Receive $3M Payment from ...   Multiple Sclerosis News Today   - 11th Mar 15
UPDATED: Merck KGaA carves into MS R&D after a string of setbacks   FierceBiotech   - 23rd Feb 15
Healthcare Sector Movers: Genetic Technologies Limited (GENE), Baxter ...   WallStreet Scope   - 21st Feb 15
Torrent Pharmaceuticals Limited v. Merck Frosst Canada & Co.: Denying ...   The National Law Review   - 15th Jan 15
Merck Ltd's MD resigns   Equity Bulls   - 19th Dec 14
Interactive Technical Analysis Chart Merck Limited ( MERCK NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Merck Limited
MERCK Business Profile
Merck is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 1,039.54 crore.The company has reported a standalone sales of Rs 207.47 crore and a Net Profit of Rs 15.77 crore for the quarter ended Sep 2013.The company management includes S N Talwar - Chairman, Claus-Dieter Boedecker - Managing Director, Narayanaswamy Krishan - Whole Time Director, H C H Bhabha - Director, E A Kshirsagar - Director, N Krishnan - Director, P H Pimplikar - Director, Peter-Ulrich Mannheimer - Director, Hans Hermansson - Director. It is listed on the BSE with a BSE Code of 500126 and the NSE with an NSE Code of MERCK.Its Registered office is at 'Shiv Sagar Estate ' A',' Dr. Annie Besant Road,,Worli Mumbai,Maharashtra - 400018.Their Registrars are Sharepro Services (India) Pvt.Ltd.